Physician profile
Abed Kanzy
NPI 1265729370
$1,174.63
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.38 · 2020: $234 · 2021: $806 · 2022: $120.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $203.82 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $183.39 | 2020-2021 | |
| Lilly USA, LLC | $155.83 | 2020-2022 | |
| Medtronic Minimed, INC. | $120.15 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $114.76 | 2021 | |
| Novo Nordisk INC | $65.14 | 2021-2022 | |
| Gilead Sciences, INC. | $41.46 | 2021 | |
| Aurinia Pharma U.S., INC. | $40.50 | 2021 | |
| Dexcom, INC. | $37.65 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.79 | 2021 | |
| Abbott Laboratories | $22.61 | 2021 | |
| Mallinckrodt Hospital Products INC. | $16.53 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.33 | 2021 | |
| Philips North America LLC | $15.91 | 2021 | |
| Advanced Respiratory, INC | $15.42 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.84 | 2020 | |
| Corcept Therapeutics | $14.38 | 2019 | |
| Medtronic, INC. | $13.60 | 2021 | |
| Tandem Diabetes Care, INC. | $13.29 | 2020 | |
| Jazz Pharmaceuticals INC. | $13.28 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $12.71 | 2020 | |
| Merck Sharp & Dohme LLC | $12.24 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abed Kanzy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.